An entrepreneur and venture investor with extensive CEO experience in venture funded
and turnaround situations in European healthcare companies. In 1997, he was appointed
Weston Medical Group's first CEO and led it from concept through several rounds
of funding to a full UK listing in 2000. Prior to this he was the first CEO of Imutran,
a Cambridge-based healthcare company that was sold to the Swiss based pharmaceutical
multinational, Novartis. He worked for the Boston Consulting Group in London prior
to joining Baxter International in 1988 where he held a succession of strategy,
sales and marketing and general management positions. Christopher holds an MA from
the University of Oxford and an MBA from the Harvard Business School.
back